Open Access

Downregulation of ubiquitin-specific peptidase 39 suppresses the proliferation and induces the apoptosis of human colorectal cancer cells

Corrigendum in: /10.3892/ol.2018.9234

  • Authors:
    • Zhiyuan Xing
    • Fengbo Sun
    • Wang He
    • Zhiwei Wang
    • Xiuqi Song
    • Fengjuan Zhang
  • View Affiliations

  • Published online on: February 15, 2018     https://doi.org/10.3892/ol.2018.8061
  • Pages: 5443-5450
  • Copyright: © Xing et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ubiquitin-specific peptidase 39 (USP39) has been reported to participate in the mitotic spindle checkpoint and the process of cytokinesis. and has been identified as a therapeutic target for various types of cancer. However, the effect of USP39 in colorectal cancer (CRC) has not been investigated. To explore the functional role of USP39 in CRC cell growth, lentivirus-mediated RNA interference was applied to inhibit USP39 expression in SW1116 and HCT116 cells. The relative USP39 mRNA and protein expression levels were significantly reduced in the USP39 knockdown cells, as verified by reverse transcription‑quantitative polymerase chain reaction and western blot analysis. USP39 knockdown significantly reduced the proliferation and colony formation abilities of CRC cells, and induced apoptosis and cell cycle arrest in the G2/M phases, as determined by an MTT assay, a colony formation assay and flow cytometry analysis. Furthermore, western blot analysis demonstrated that USP39 knockdown may have induced apoptosis through the upregulation of p53, p‑p53, PARP and caspase‑3 expression in SW1116 cells. In conclusion, USP39 may be a novel biological marker for targeted therapy against CRC, and requires further investigation.

Introduction

Colorectal cancer (CRC) is one of the most fatal types of cancer worldwide (1). A range of chemotherapeutic drugs and other methods are available for the treatment of CRC, but the associated side effects hamper their clinical application and efficacy (2). With the development of molecular-targeted therapies, progress has been made in cancer therapy. In recent years, a number of molecules have been identified as targets for molecular-targeted anticancer drugs, including growth factors, factors regulating cell survival and molecules associated with the cell cycle (3). There is a critical need to identify potential molecular targets and improve the therapy of CRC.

Ubiquitin-specific peptidase 39 (USP39) is a deubiquitinating enzyme containing a central zinc finger and two ubiquitin C-terminal hydrolase domains (4). USP39 is critical in the process of pre-mRNA splicing, but does not exhibit ubiquitin-specific peptidase activity (5). As a 65 kDa SR protein of the U4/U6.U5 tri-small nuclear ribonucleoprotein complex, USP39 also functions in the assembly of the mature spliceosome complex and is indispensable in maintaining the integrity of the mitotic spindle checkpoint (6,7). A previous study indicated that USP39 silencing induced defective chromosome segregation and cytokinesis in U2OS cells, indicating USP39 is critical in the regulation of mitosis (7). Furthermore, the pro-growth effect of USP39 in cancer cells has been widely investigated. Wen et al (8) demonstrated that the overexpression of USP39 promoted the proliferation of prostate cancer cells, which is in accord with a study by Wang et al (9) in breast cancer cells. Furthermore, USP39 knockdown has been demonstrated to affect cell cycle distribution by inducing arrest in the G2/M phase, and to promote apoptosis, in human hepatocellular carcinoma (10) and medullary thyroid carcinoma (11) cells, indicating that USP39 may be a feasible target for the molecular therapy of various types of cancer. However, limited data regarding the biological function of USP39 in CRC cells is available.

Therefore, the effect of USP39 in CRC cells was assessed in the present study. Lentivirus-delivered short hairpin RNA (shRNA) was used to infect CRC cells to facilitate loss-of-function analysis. The function of USP39 knockdown on the proliferation, colony formation ability, cell cycle progression and apoptosis of CRC cells was investigated. To the best of our knowledge, this is the first study to demonstrate that USP39 is associated with CRC cell proliferation.

Materials and methods

Cell lines and cell culture

SW1116 and HCT116 human CRC cells, and 293T cells were purchased from the Cell Bank of Chinese Academy of Sciences (Shanghai, China). SW1116 and 293T cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) with 10% fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc.). HCT116 cells were cultured in RPMI-1640 (Hyclone; GE Healthcare Life Sciences, Logan, UT, USA) supplemented with 10% FBS. All cells were maintained at 37°C in a humidified incubator with 5% CO2.

Construction of lentiviral particles and USP39 knockdown

To silence the expression of USP39, two candidate shRNAs for human USP39, based on the Gen Bank sequence NM_001256725.1, were designed (KD-1 and −2). The shRNA sequences targeting USP39 were as follows: KD-1, 5′-GATTTGGAAGAGGCGAGATAACTCGAGTTATCTCGCCTCTTCCAAATC-3′; KD-2, 5′-CCTTCCAGACAACTATGAGATCTCGAGATCTCATAGTTGTCTGGAAGG-3′. A non-silencing shRNA with the sequence, 5′-TTCTCCGAACGTGTCACGTCTCGAGACGTGACACGTTCGGAGAA-3′, was used as a negative control (shCon). The oligos were annealed and inserted into pFH-L plasmids (Shanghai Holly Lab, Shanghai, China), which included a green fluorescent protein (GFP) tag. The lentiviral particles were constructed in 293T cells as described in a previous study (12). SW1116 and HCT116 cells were incubated in 6-well plates and infected with KD or shCon for 96 h with a multiplicity of infection of 30. Successful infection was confirmed by the observation of GFP expression with fluorescence microscopy (DMI4000B; Leica Microsystems GmbH, Wetzlar, Germany). The efficiency of knockdown was determined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blot analyses. All experiments were repeated in triplicate.

RT-qPCR analysis

Cells were harvested at 5 days after lentiviral infection. TRIzol reagent (Thermo Fisher Scientific, Inc.) was used to extract total RNA, according to the manufacturer's instructions. Single-stranded cDNA was synthesized using Superscript II Reverse Transcriptase (Invitrogen; Thermo Fisher Scientific, Inc.). The primers were as follows: USP39 forward, 5′-GCCAGCAGAAGAAAAAGAGC-3′ and reverse, 5′-GCCATTGAACTTAGCCAGGA-3′; β-actin (endogenous control) forward, 5′-GTGGACATCCGCAAAGAC-3′ and reverse, 5′-AAAGGGTGTAACGCAACTA-3′. The mRNA levels of USP39 were determined using SYBR Green on the Bio-Rad Connect Real-Time PCR system (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The total PCR reaction volume was 20 µl, including 10 µl 2X SYBR Premix Ex Taq (Takara Bio, Inc., Otsu, Japan), 0.5 µl primers (2.5 µM), 5 µl cDNA and 4.5 µl ddH2O. The PCR thermocycling procedure was as follows: Initial denaturation at 95°C for 1 min, followed by 40 cycles of denaturation at 95°C for 5 sec and extension at 60°C for 20 sec. The relative gene expression levels were calculated and compared using the 2−ΔΔCq method (13).

Western blot analysis

Cells were harvested and lysed in 2X protein lysis buffer [10 mM EDTA, 100 mM Tris-HCl (pH 6.8), 4% SDS and 10% glycine] 5 days after lentiviral infection. Protein lysates were collected by centrifugation at 12,000 × g for 15 min at 4°C. Equal amount of protein samples (30 µg) were separated on 10% SDS-PAGE and transferred to a PVDF membrane at 300 mA for 1.5 h. Then the membrane was blocked with Tris-buffered saline with 0.1% Tween-20 containing 5% non-fat dried milk for 1 h at room temperature, and probed with the corresponding primary antibodies. Primary antibodies included mouse anti-p53 (dilution 1:1,000; sc-126; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), rabbit anti-p-p53 (dilution 1:500; cat. no. 2528), rabbit anti-caspase-3 (dilution 1:500; cat. no. 9661), rabbit anti-poly(ADP-ribose) polymerase (PARP; dilution 1:1,000; cat. no. 9542; all from Cell Signaling Technology, Inc., Danvers, MA, USA) and rabbit anti-GAPDH (dilution 1:100,000; cat. no. 10494-1-AP; Protein Tech Group, Inc., Chicago, IL, USA). The membranes were immunoblotted with the appropriate primary antibodies at 4°C overnight, and then incubated with a HRP-conjugated goat anti-rabbit (dilution 1:5,000; cat. no. SC-2054) or goat anti-mouse antibody (dilution 1:5,000; cat. no. SC-2005; both from Santa Cruz Biotechnology, Inc.) as appropriate for 2 h at room temperature. Signals were detected using Super ECL Detection Reagent (Applygen Technologies, Inc., Beijing, China).

MTT assay for cell viability

SW1116 and HCT116 cells were seeded at 2,000 cells/well in 96-well plates at 4 days after infection. MTT solution (20 µl) was added into each well, and incubated for a further 4 h at 37°C. The supernatant was removed and 100 µl acidic isopropanol (10% SDS, 5% isopropanol and 0.01 mol/l HCl) was added to each well. The absorbance values at 595 nm were determined using a microplate reader.

Colony formation assay

Stably transfected SW1116 (500 cells/well) and HCT116 (400 cells/well) cells were seeded into 6-well plates. Following incubation for 8 days (SW1116) or 7 days (HCT116), cells were washed in ice-cold PBS and fixed with methanol at the temperature of 37°C for 15 min. Then crystal violet (Beyotime Institute of Biotechnology, Haimen, China) staining was performed, according to the manufacturer's instructions. The total number of colonies, defined as groups of >50 cells, was counted under light microscopy. The colony images were analyzed using Metamorph software version 7.5 (Molecular Devices LLC, Sunnyvale, CA, USA).

Cell cycle analysis

To investigate the mechanisms underlying the effects of USP39 on cell growth, cell cycle distribution was examined by flow cytometry and propidium iodide (PI) staining. SW1116 (7×104 cells/well) and HCT116 (2×105 cells/well) cells were harvested at 7 days and 5 days after infection, respectively. Cells were fixed in 70% ice-cold ethanol for 4 h and washed twice with cold PBS. The fixed cells were stained with PI and detected by a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, USA) according to the manufacturer's protocol. The results were analyzed using FlowJo software version 7.6.2 (FlowJo LLC, Ashland, OR, USA).

Apoptosis analysis

To further confirm whether the effect of USP39-knockdown on cell proliferation was associated with apoptosis, flow cytometry with Annexin V-APC/7-AAD double staining was performed on SW1116 cells. Briefly, at 7 days after infection, SW1116 cells (8×104 cells/dish) were seeded in 6-cm dishes and cultured for a further 48 h. Then the cells were collected, double stained using Annexin V-APC and 7-AAD according to the manufacturer's protocol (Nanjing Key Gen Biotech Co., Ltd., Nanjing, China), and detected by a FACSCalibur flow cytometer.

Statistical analysis

All experiments were repeated in triplicate and the results were presented as the mean ± standard deviation of three independent experiments using GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA, USA). Analysis was performed with a one-way analysis of variance followed by Dunnett's multiple comparisons test. P<0.05 was considered to indicate a statistically significant difference.

Results

Lentivirus-mediated RNAi suppresses the expression of USP39

To investigate the effects of USP39 in CRC, the expression of USP39 was knocked down in SW1116 and HCT116 cells using lentivirus-mediated transfection. As shown in Fig. 1, >80% of the cells expressed GFP following infection with shRNA targeting USP39 (KD-1 and −2) or control shRNA (shCon), suggesting that the recombinant lentivirus generated high infection efficiency in CRC cells. RT-qPCR analysis indicated that the USP39 mRNA levels were significantly downregulated in the KD-1 and 2 groups compared with the shCon and Con groups of SW1116 and HCT116 cells (Fig. 2A; P<0.0001). Consistent with this, USP39 protein levels were also downregulated in the KD-1 and −2 groups of SW1116 and HCT116 cells (Fig. 2B). Therefore, it was demonstrated that both shRNAs against USP39 exerted knockdown effects on USP39 expression.

USP39 knockdown inhibits CRC cell viability and colony formation

To determine the role of USP39 expression on CRC cell viability, an MTT assay was performed on SW1116 and HCT116 cells. As included in Fig. 3A, the viability of cells of SW1116 cells in the KD-1 (P<0.0001) and KD-2 (P<0.001) groups was significantly decreased compared with the shCon and Con groups. A similar result was achieved in HCT116 cells (Fig. 3B; both P<0.0001). KD-1 suppressed cell viability to a greater extent than KD-2 in the SW1116 and in HCT116 cells, and was therefore selected for use in further procedures.

The colony formation capacity of SW1116 and HCT116 cells was then determined for Con, shCon and KD-1 cells. Representative images of the size of each colony and the number of colonies per well are provided in Fig. 4. Analysis indicated that the number of colonies was reduced in the KD-1 group, compared with the Con and shCon groups, for SW1116 and HCT116 (Fig. 4; P<0.0001).

USP39 knockdown inhibits cell cycle progression

Cell proliferation is controlled by cell cycle progression. Therefore, cell cycle distribution was analyzed with FACS in SW1116 and HCT116 cells subsequent to USP39 knockdown (Fig. 5A). As presented in Fig. 5B, the proportion of SW1116 and HCT116 cells in the G0/G1 (SW1116, P<0.0001; HCT116, P<0.05) and S (both P<0.01) phases was significantly reduced, and the proportion in the G2/M phase significantly increased (both P<0.0001) in the KD-1 group compared with the Con and shCon groups. These results indicated that USP39 may have regulated cell proliferation through an effect on cell cycle distribution. In addition, more cells in the sub-G1 phase and therefore, undergoing apoptosis, were detected in SW1116 and HCT116 cells subsequent to USP39 knockdown (Fig. 5C; both P<0.0001).

USP39 knockdown promotes apoptosis

To further investigate the apoptosis-promoting effects of USP39 silencing in CRC cells, SW1116 cells were analyzed with Annexin V-APC/7-AAD double staining and flow cytometry (Fig. 6A). As demonstrated in Fig. 6B, the knockdown of USP39 increased the proportion of cells at early (Annexin V+/7-AAD-) and late (Annexin V+/7-AAD+) apoptotic stages by ~2-fold compared with the Con and shCon groups (P<0.0001). This data demonstrated that USP39 silencing induced apoptosis in SW1116 cells. In addition, the expression levels of apoptotic markers, including PARP, p53 and caspase-3, were also assessed in SW1116 cells. As depicted in Fig. 6C, the expression levels of p53, p-p53, PARP and caspase-3 were increased in SW1116 cells following KD-1 infection. Thus, it was demonstrated that the knockdown of USP39 in SW1116 cells induced apoptosis via altering the expression of apoptosis-associated proteins.

Discussion

CRC is one of the leading causes of cancer mortality, and results from uncontrolled cell growth in the colon, rectum or appendix (14). Molecular-targeted therapies may present a powerful treatment option for CRC. Thus, the present study focused on the identification of an oncogenic target in CRC and investigated the biological effects of silencing the identified gene.

In the present study, it was demonstrated that the knockdown of USP39 by USP39-specific shRNA could significantly suppress the growth and colony formation abilities of the CRC cell lines SW1116 and HCT116. It was previously identified that spliceosome factors are associated with cancer development (15,16). As a confirmed spliceosome factor, USP39 is critical to maintain the spindle checkpoint and promote successful cytokinesis through the regulation of Aurora B mRNA splicing in mammalian cells (7). The downregulation of Aurora B leads to defects in spindle checkpoint function and cytokinesis (7). This indicates that USP39 may affect proliferation via affecting Aurora B mRNA splicing. In addition, flow cytometry analysis in the present study identified that the knockdown of USP39 induced cell cycle arrest in the G2/M phases, which may have induced the inhibition of proliferation. These results correspond with a previous study, which indicated that the knockdown of USP39 markedly suppressed the proliferation of TT medullary thyroid carcinoma cells (11).

It was identified in the present study that cells accumulated in the sub-G1 phase, indicative of the induction of apoptosis. Further analysis confirmed that USP39 silencing significantly promoted the apoptosis of SW1116 cells. Apoptosis is a caspase-dependent form of programmed cell death (17), which is necessary for the maintenance of bodily health (18). Caspase-3 is the key enzyme in the process of apoptosis (19); once activated, it cleaves specific substrates, including PARP, to mediate apoptosis (20,21). The transcription factor p53, a tumor suppressor, is phosphorylated and activated as a reaction to DNA damage, leading to growth arrest and the induction of cell death (22). Consistent with the results of the present study, the level of p53 expression and PARP cleavage have been demonstrated to increase during the cell cycle arrest and apoptosis of CRC cells (23). Taken together, it can be concluded that the growth inhibition associated with USP39 silencing in CRC cells may have been induced by the induction of spliceosome factor-associated apoptosis.

In conclusion, the present study has revealed that USP39 silencing suppressed CRC cell proliferation via activating the caspase cascade and upregulating the expression of p53. These data may provide an experimental basis for the development of USP39 as a potential molecular target against CRC. Further investigation is required to verify the efficacy of USP39-targeted therapy in vivo.

Acknowledgements

Not applicable.

Funding

No funding was received.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

ZX performed the experiments and drafted the manuscript. FS and WH participated in the experiments. ZW and XS participated in the data analysis and figure format. FZ participated in the research design, the article reviewing and the data examining.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Gansler T, Ganz PA, Grant M, Greene FL, Johnstone P, Mahoney M, Newman LA, Oh WK, Thomas CR Jr, Thun MJ, et al: Sixty years of CA: A cancer journal for clinicians. CA Cancer J Clin. 60:345–350. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Li Q, Zhou S, Jing J, Yang T, Duan S, Wang Z, Mei Q and Liu L: Oligosaccharide from apple induces apoptosis and cell cycle arrest in HT29 human colon cancer cells. Int J Biol Macromol. 57:245–254. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Allgayer H and Fulda S: An introduction to molecular targeted therapy of cancer. Adv Med Sci. 53:130–138. 2008. View Article : Google Scholar : PubMed/NCBI

4 

Lygerou Z, Christophides G and Seraphin B: A novel genetic screen for snRNP assembly factors in yeast identifies a conserved protein, Sad1p, also required for pre-mRNA splicing. Mol Cell Biol. 19:2008–2020. 1999. View Article : Google Scholar : PubMed/NCBI

5 

Hadjivassiliou H, Rosenberg OS and Guthrie C: The crystal structure of S. cerevisiae Sad1, a catalytically inactive deubiquitinase that is broadly required for pre-mRNA splicing. RNA. 20:656–669. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Makarova OV, Makarov EM and Luhrmann R: The 65 and 110 kDa SR-related proteins of the U4/U6.U5 tri-snRNP are essential for the assembly of mature spliceosomes. EMBO J. 20:2553–2563. 2001. View Article : Google Scholar : PubMed/NCBI

7 

van Leuken RJ, Luna-Vargas MP, Sixma TK, Wolthuis RM and Medema RH: Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of aurora B. Cell Cycle. 7:2710–2719. 2008. View Article : Google Scholar : PubMed/NCBI

8 

Wen D, Xu Z, Xia L, Liu X, Tu Y, Lei H, Wang W, Wang T, Song L, Ma C, et al: Important role of SUMOylation of Spliceosome factors in prostate cancer cells. J Proteome Res. 13:3571–3582. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Wang H, Ji X, Liu X, Yao R, Chi J, Liu S, Wang Y, Cao W and Zhou Q: Lentivirus-mediated inhibition of USP39 suppresses the growth of breast cancer cells in vitro. Oncol Rep. 30:2871–2877. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Pan Z, Pan H, Zhang J, Yang Y, Liu H, Yang Y, Huang G, Ni J, Huang J and Zhou W: Lentivirus mediated silencing of ubiquitin specific peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro. Biol Res. 48:182015. View Article : Google Scholar : PubMed/NCBI

11 

An Y, Yang S, Guo K, Ma B and Wang Y: Reduced USP39 expression inhibits malignant proliferation of medullary thyroid carcinoma in vitro. World J Surg Oncol. 13:2552015. View Article : Google Scholar : PubMed/NCBI

12 

Sun W, Yao L, Jiang B, Guo L and Wang Q: Spindle and kinetochore-associated protein 1 is overexpressed in gastric cancer and modulates cell growth. Mol Cell Biochem. 391:167–174. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

14 

de-Freitas Junior JC and Morgado-Diaz JA: The role of N-glycans in colorectal cancer progression: Potential biomarkers and therapeutic applications. Oncotarget. 7:19395–19413. 2016.PubMed/NCBI

15 

Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K, Werner L, Sivachenko A, DeLuca DS, Zhang L, et al: SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med. 365:2497–2506. 2011. View Article : Google Scholar : PubMed/NCBI

16 

Cazzola M, Rossi M and Malcovati L; Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative, : Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms. Blood. 121:260–269. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Salvesen GS and Dixit VM: Caspases: Intracellular signaling by proteolysis. Cell. 91:443–446. 1997. View Article : Google Scholar : PubMed/NCBI

18 

Shimizu S, Yoshida T, Tsujioka M and Arakawa S: Autophagic cell death and cancer. Int J Mol Sci. 15:3145–3153. 2014. View Article : Google Scholar : PubMed/NCBI

19 

Fan TJ, Han LH, Cong RS and Liang J: Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai). 37:719–727. 2005. View Article : Google Scholar : PubMed/NCBI

20 

Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M, Bus CJ, Kadkhoda K, Wiechec E, Halayko AJ and Los M: Apoptosis and cancer: Mutations within caspase genes. J Med Genet. 46:497–510. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Matuo R, Sousa FG, Escargueil AE, Grivicich I, Garcia-Santos D, Chies JA, Saffi J, Larsen AK and Henriques JA: 5-Fluorouracil and its active metabolite FdUMP cause DNA damage in human SW620 colon adenocarcinoma cell line. J Appl Toxicol. 29:308–316. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Vousden KH and Lane DP: p53 in health and disease. Nat Rev Mol Cell Biol. 8:275–283. 2007. View Article : Google Scholar : PubMed/NCBI

23 

Thorenoor N, Faltejskova-Vychytilova P, Hombach S, Mlcochova J, Kretz M, Svoboda M and Slaby O: Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer. Oncotarget. 7:622–637. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April-2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xing Z, Sun F, He W, Wang Z, Song X and Zhang F: Downregulation of ubiquitin-specific peptidase 39 suppresses the proliferation and induces the apoptosis of human colorectal cancer cells Corrigendum in /10.3892/ol.2018.9234. Oncol Lett 15: 5443-5450, 2018.
APA
Xing, Z., Sun, F., He, W., Wang, Z., Song, X., & Zhang, F. (2018). Downregulation of ubiquitin-specific peptidase 39 suppresses the proliferation and induces the apoptosis of human colorectal cancer cells Corrigendum in /10.3892/ol.2018.9234. Oncology Letters, 15, 5443-5450. https://doi.org/10.3892/ol.2018.8061
MLA
Xing, Z., Sun, F., He, W., Wang, Z., Song, X., Zhang, F."Downregulation of ubiquitin-specific peptidase 39 suppresses the proliferation and induces the apoptosis of human colorectal cancer cells Corrigendum in /10.3892/ol.2018.9234". Oncology Letters 15.4 (2018): 5443-5450.
Chicago
Xing, Z., Sun, F., He, W., Wang, Z., Song, X., Zhang, F."Downregulation of ubiquitin-specific peptidase 39 suppresses the proliferation and induces the apoptosis of human colorectal cancer cells Corrigendum in /10.3892/ol.2018.9234". Oncology Letters 15, no. 4 (2018): 5443-5450. https://doi.org/10.3892/ol.2018.8061